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Pore-forming proteins insert from solution into mem-
branes to create lesions, undergoing a structural re-
arrangement often accompanied by oligomerization.
Lysenin, a pore-forming toxin from the earthworm
Eisenia fetida, specifically interacts with sphingo-
myelin (SM) and may confer innate immunity against
parasites by attacking their membranes to form
pores. SM has important roles in cell membranes
and lysenin is a popular SM-labeling reagent. The
structure of lysenin suggests common ancestry
with other pore-forming proteins from a diverse set
of eukaryotes and prokaryotes. The complex with
SM shows the mode of its recognition by a protein
in which both the phosphocholine headgroup and
one acyl tail are specifically bound. Lipid interaction
studies and assays using viable target cells confirm
the functional reliance of lysenin on this form of SM
recognition.
INTRODUCTION
Pore-forming proteins have evolved in all kingdoms of life, and
are increasingly understood to exist in a limited number of
superfamilies. The cholesterol-dependent cytolysins (CDCs) of
Gram-positive bacteria, for instance, are structurally related
to the membrane-attack complex/perforin (MACPF) family of
proteins found in humans and Plasmodium (Amino et al., 2008;
Anderluh and Lakey, 2008; Rosado et al., 2008). Another family
is exemplified by aerolysin from Aeromonas hydrophila (Parker
et al., 1994) and ε-toxin from Clostridium perfringens but
includes also the fungal Laetiporus sulphureus lytic lectin (LSL)
(Anderluh and Lakey, 2008; Cole et al., 2004; Manchen˜o et al.,
2005). Thus, once evolved, the structure of individual domains,
i.e., pore-forming modules (PFMs), seems remarkably well con-1498 Structure 20, 1498–1507, September 5, 2012 ª2012 Elsevier Ltserved. Although the amino acid sequence can change almost
completely, the topology of the module remains preserved. In
this study, we describe the structure of an additional member
of the aerolysin family.
Commonly, pore-forming proteins engage a lipid or protein
binding partner to recognize the targetmembrane. Subsequently
they oligomerize on the surface of the bilayer and then insert into
it to form a lesion. In this process, all pore-forming proteins must
undergo a structural rearrangement to convert themselves from
a soluble state to a membrane-inserted one (Anderluh and
Lakey, 2008; Gilbert, 2010). This is frequently a remarkable
transformation, such as the conversion of an a-helical structure
in the soluble form of the protein to a b sheeted form in the
membrane (Gilbert, 2005; Shatursky et al., 2000; Tilley et al.,
2005), or vice versa (Mueller et al., 2009). The region that finally
spans the membrane has consistently been found to be amphi-
pathic in nature, in order to interface simultaneously with the
aqueous pore and the hydrophobic acyl chains of the bilayer
interior (Shatursky et al., 2000; Song et al., 1996). How proteins
specifically bind to and recognize lipids is understood compara-
tively poorly, as only a small number of lipid:protein complex
structures have been resolved. For example, lipids have been
observed in a study of aquaporin-0 crystals: the path of the lipid
chains across the surface of the protein was identified and
found to be essentially determined by the acyl chain, irrespective
of the lipid headgroup involved (Hite et al., 2010).
Lysenin from the earthworm Eisenia fetida is a pore-forming
protein that specifically interacts with sphingomyelin (SM) and
may confer innate immunity against parasites by attacking their
membranes (Bruhn et al., 2006; Cooper et al., 2001). Lysenin
has come to be valued as a label for SM, a sphingolipid critical
for bilayer structure and function (Gault et al., 2010), in cell
membranes (Hullin-Matsuda et al., 2009; Ishitsuka and Kobaya-
shi, 2004). Studying the structure of lysenin bound to SM has
the potential to reveal molecular details of the specific recogni-
tion of a lipid by a protein and to suggest a mechanism for
the process of pore formation. Here we report the crystal struc-
ture of lysenin alone, and in complex with the sphingomyelind All rights reserved
Figure 1. Lysenin Crystal Structure
(A) Cartoon representation of the lysenin crystal structure shows it is organized
into two domains: the PFM domain at the N-terminus made of subdomain 1
(red), subdomain 2 (blue) and the b-hairpin (orange); the b-trefoil C-terminal
domain colored in cyan.
(B) Lysenin protomer topology diagram. Color code is the one adopted in (A).
(C) Superpositions of apo and POC-bound form of lysenin, respectively in
violet and green. Superposing the PFM domains shows the alternative orien-
tations of the head with respect to the N-terminal domain.
Structure
Structure of Lysenin and Binding to Sphingomyelinheadgroup phosphocholine (POC), and with SM itself. The
topology of the lysenin structural fold establishes it as a member
of the aerolysin family of pore-forming proteins (Szczesny et al.,
2011), which appears thus to be conserved from bacteria to
annelids. The complex with SM shows how lysenin recognizes
SM at full stretch, binding both its POC headgroup and its acyl
tail. The headgroup is bound electrostatically but the tail is bound
by ring-stacking-like interactions involving two critical tyrosine
residues. We also find an additional POC-binding site, which
indicates how lysenin might be guided in its attack on the target
membrane. The SM-bound structure suggests that specific resi-
dues are involved in recognition of the lipid and by site-directed
mutagenesis we confirm their importance using lipid binding
assays and live cell imaging of target cells.
RESULTS
Overall Structure of Lysenin
The crystal structure of lysenin was first determined in space
group P6522, with one molecule per asymmetric unit (a.u.), by
multiple isomorphous replacement with anomalous scattering
(MIRAS, one SeMet and one Hg derivative) and then in space
group P1 with four molecules per a.u. by molecular replacement.
The structure reveals that lysenin has two domains. The elon-
gated N-terminal domain consists of a 310 helix and 10 b strands,
six of which belong to a highly twisted antiparallel b sheetStructure 20, 1498–15(Figures 1A and 1B). The N-terminal domain can be divided
into two subdomains; subdomain 1 has a b sandwich formed
by a two- and a three-stranded antiparallel b sheet. Subdomain
2 consists of a double-turn 310 helix, a b sandwich formed by
a three- and four-stranded antiparallel b sheet and a b-hairpin
within an additional long loop. The C terminus of lysenin is
composed of a b-trefoil motif with a six-stranded antiparallel
b-barrel capped on one end by three two-stranded hairpins
and a single-turn 310 helix (Figures 1A and 1B). The five crystal-
lographically independent copies of the molecule (see Experi-
mental Procedures and Table 1), define an 45 arc that is
subtended by the C-terminal domains hinging at residues 159–
168 (Figure 1C).
Similarity to Pore-Forming Toxins of Known Structure
The N terminus of lysenin is immediately reminiscent of other
pore-forming proteins. Using the lysenin N-terminal domain as
a probe in DALI (Holm and Rosenstro¨m, 2010), four structures
with high similarity are found: the lytic lectin of the mushroom
Laetiporus sulphureus (LSL) (1w3a-A, Z = 4.7, root-mean-square
deviation [rmsd]Ca = 4.9, a carbon positions aligned = 98/312
residues) (Manchen˜o et al., 2005), Gram-positive Clostridium
perfringens ε-toxin (1uyj-B, Z = 4.5, rmsdCa = 4.1, a carbon posi-
tions aligned = 102/289 residues) (Cole et al., 2004), Bacillus
thuringiensis parasporin-2 toxin (2ztb-A, Z = 4.5, rmsdCa = 3.7,
a carbon positions aligned = 95/246 residues) (Akiba et al.,
2009), and aerolysin from the heterotrophic Gram-negative
bacterium Aeromonas hydrophila (3g4o-A, Z = 3.6, rmsdCa =
4.7, a carbon positions aligned = 98/460 residues) (Iacovache
et al., 2011) (Figure 2A). This finding indicates that the N terminus
is indeed the pore-forming module (PFM) of lysenin. Notably, the
lysenin PFM aligns with the functionally equivalent regions of
homologous proteins, such as the PFMs of ε-toxin and para-
sporin (Cole et al., 2004; Akiba et al., 2009). Thus, although lyse-
nin is an annelid protein, it is clearly evolutionarily related to
a family of pore-forming proteins found in prokaryotes, as shown
in the structural phylogenetic tree (Figure 2B). Interestingly,
although both eukaryotic, lysenin, and LSL lie on independent
branches of the phylogenetic tree and as distant from each other
as they are from the prokaryotic family members. The structural
comparisons made here are in agreement with a recent bio-
informatics analysis (Szczesny et al., 2011) that argued that lyse-
nin belongs to the extended aerolysin family characterized by
a conserved core b sheet structure elaborated by insertions
specific to each family member. For example lysenin has an
additional b-hairpin and a double-turn 310 helix after the so-
called ‘‘insertion loop,’’ which like those of related proteins
displays an alternating pattern of hydrophobic and hydrophilic
residues running from residues Met44 to Gly67 (subdomain 2)
(Figure 2C). This patterning is typical for regions of pore-forming
proteins undergoing a refolding transition from a solution state to
a membrane-inserted state and suggests that the bilayer-pene-
trating region of the structuremakes use of this region (Shatursky
et al., 2000; Song et al., 1996). Members of the aerolysin family
contain a surface patch of Ser and Thr residues that may have
a role in oligomerization or in positioning of the protein on the
membrane before membrane insertion (Akiba et al., 2009). This
feature is also found in the PFM of lysenin (Figure S1 available
online).07, September 5, 2012 ª2012 Elsevier Ltd All rights reserved 1499
Table 1. Data Collection, Phasing, and Refinement Statistics
Crystal Form Lysenin-Se-Met Lysenin-Hga Lysenin:SM Native Lysenin
Space group P6522 P6522 C2 P1
Unit cell dimensions
a, b, c (A˚) 98.1, 98.1, 184.172 98.43, 98.43, 184.68 211.26, 37.22, 96.79 58.91, 85.56, 108.81
a, b, g 90, 90, 120 90, 90, 120 90.0, 104.02, 90.0 98.877, 96.845, 90.036
Resolution (A˚) 32.11–2.84 (2.92–2.84) 33.59–2.54 (2.68–2.54) 62.142–3.1 44.36–3.3 (3.48–3.3)
Rmerge 0.104 (0.843) 0.051 (0.561) 0.09 (0.578) 0.159 (0.46)
Rpim 0.025 (0.155) 0.014 (0.146) 0.055 (0.349) 0.1 (0.291)
I/s(I) 29.0 (4.9) 33 (5.2) 11.5 (2.2) 8.3 (2.8)
Completeness 99.9 (99.9) 99.3 (98.3) 99.7 (99.5) 97.79 (97.4)
Wave length (A˚) Peak: 0.97867
Remote: 0.9077
1.00941 0.9763 0.9537

















Protein 2,355 4,657 9,277
Ligands/ions 44/28 36/15 48/43
Water 24 5 8
Total 2,451 4,713 9,376
Average B-factor (A˚2)
Protein 75.7 98.8 68.9
Water 40.5 46.2 17.5
Ligands/ions 75/97 104/125 80.4/80
Resolution (A˚) 23.70–2.84 50.38–3.12 29.09–3.3
Rwork/Rfree (%) 22.35/26.40 24.03/27.07 21.3/23.6
Rmsd
Bonds (A˚) 0.009 0.007 0.07
Angles () 1.1 0.94 0.94
Dihedrals () 2.97 2.75 2.58
Mol probity score (%) 2.50 (91) 1.54 (100) 1.71 (100)
Ramachandran plot
Favored 94.22 (%) 93.99 (%) 95.25 (%)
Outliers 0 (%) 0.34 (%) 0.60 (%)
Rmerge = SjI(h,i)  < I(h) > j/SI(h,i), where < I(h) > is the mean intensity of reflections. Rpim = precision indicating Rmerge factor. Rwork and Rfree were
calculated from working and test set reflections. Values for the highest resolution shells are given in parenthesis. Bijvoet pairs are merged.
aN-terminal domain disordered, thus did not carry out refinement.
bPhasing power is the root-mean-square (rms) value of Fh divided by the rms lack-of-closure, as given by SHARP. Isomorphous and anomalous
difference phasing powers are given, respectively.
cValues in parentheses refer to the resolution at which the Phasing power reaches 1.0.
Structure
Structure of Lysenin and Binding to SphingomyelinPhosphocholine Binding Pocket
In the crystal form with space group P6522 the protein was
found in complex with a phosphocholine molecule (lysenin:POC)
(Figure 3A). This lipid headgroup binds specifically within
the b-trefoil via a hydrogen bond network involving residues
Tyr233, Ser227, Tyr282, and a salt bridge interaction with
Lys185. Residue Gln229 is the gate regulating access to the1500 Structure 20, 1498–1507, September 5, 2012 ª2012 Elsevier LtPOC binding pocket (Figure 3A): in the apo forms of lysenin,
Gln229 is in a closed conformation, blocking the entrance to
the POC binding site, but has opened in the POC bound state
(see Movie S1). Lys185 aids in defining the gate, as it is in
a different conformer in the apo form, preventing interaction
with the phosphate moiety. Unlike other b sheeted POC-binding
proteins, such as staphylococcal LukF, the POC pocket ofd All rights reserved
Figure 2. Conservation of the PFM across
Homologs
(A) Gallery of lysenin homologs identified by DALI
(http://ekhidna.biocenter.helsinki.fi/dali_server),
using the lysenin PFM as probe.
(B) Structural phylogenetic tree expressing the
evolutionary distance as rmsd of superposed PFM
domains: lysenin-LSL, 1.65 A˚; lysenin-ε toxin,
1.87 A˚; lysenin-aerolysin, 1.88 A˚; lysenin-para-
sporin2, 1.65 A˚.
(C) Multiple sequence alignment of the putative
transmembrane hairpin form homologs described
in (A) shows that alternating pattern of hydro-
phobic/hydrophilic residues despite the very low
sequence conservation. Alignment was built using
CLUSTAW and the figure was prepared with
ESPript2.2 server (http://espript.ibcp.fr/ESPript/
ESPript/).
See also Figure S1.
Structure
Structure of Lysenin and Binding to Sphingomyelinlysenin does not involve cation-p interactions between the
electron-rich systems of the tyrosine aromatic rings (Olson
et al., 1999), but it is similar to that found in actinoporins
(Manchen˜o et al., 2003). A global analysis of the lysenin surface
electrostatic potential reveals that there is a greater concen-
tration of positive charges in the lysenin b-trefoil C terminus
than in the N-terminal PFM (Figure 3B).
Structure of Lysenin Bound to Sphingomyelin
The crystal structure of lysenin bound to sphingomyelin (SM)
was determined in the spacegroup C2 by molecular replace-
ment. To our knowledge, this is the first crystal structure of SM
bound to a protein and it shows simultaneous recognition of
hydrophilic and hydrophobic portions of the lipid. A binding
site for the lipid head group at the top of the PFM is partnered
by interaction with one of the two hydrophobic tails of a pair of
aromatic residues on the edge of a b sheet (Figure 3C) (see Fig-
ure S2 for an omit map; the other SM tail appears to be disor-
dered). A long groove along the edge of the PFM then contains
the SM tail (Figure 3C). The crystals exhibited two molecules
in the asymmetric unit, one bound to SM and one not. The
SM-bound copy has a different conformation in subdomain 1
of the PFM to the protein structure without SM bound, because
it has opened up into a more loosely packed arrangement
(see also Movie S2). The SM binding site is the most striking
feature, because the fatty acid moiety of the lipid flanks the
edge b strand 2 of the PFM the way an additional polypeptide
strand would. Residues Glu128, Gln117, and Lys21 interact
with the SM head group, making a hydrophilic binding site,
and the main-chain CO group of Gly23 interacts with the
phosphate moiety at the SM head by hydrogen bonding. The
single SM hydrophobic tail resolved is held nearly parallel to
a b strand of the PFM by the side chains of Tyr24 and Tyr26,
which form van der Waals interactions with the SM tail, creating
a sort of aromatic platform to hold the tail in place. However, the
SM:lysenin complex seems to be in a pre-pore state, because
it has not yet undergone reconfiguration or oligomerized to
a membrane-inserted form.Structure 20, 1498–15Correlation between SM Binding Ability and Lytic
Activity of Lysenin
To confirm the authenticity of the SM binding site shown in our
SM:lysenin crystal structure, we carried out alanine site-directed
mutagenesis of Lys21, Gln117, Glu128, and generated a double
alanine mutant of Tyr24 and Tyr26. All the lysenin variants were
successfully purified and produced fluorescence spectra
comparable to the WT protein (Figure S3). However, surface
plasmon resonance (SPR) experiments on the lysenin mutants
reveal that mutation of Lys21, Glu128, and Gln117 reduce SM
binding (Figure 3D), whereas the double tyrosine mutant almost
abolishes SM binding ability, as predictable on the base of our
SM:lysenin crystal structure. This is also supported by a lipid
dot-blot analysis showing SM binding by WT protein but not by
the double tyrosine mutant (Figure 3D). Previously published
work (Kiyokawa et al., 2004; Kwiatkowska et al., 2007) has
described how the mutation Trp20Ala in the PFM of lysenin
somewhat reduces SM binding and renders lysenin unable to
oligomerize and lytically inactive. Our structure shows that the
Trp20Ala mutant does not directly interact with the SM but
ensures correct orientation of the SM-interacting Lys21 and
stabilizes the PFM fold.
To ensure that the effects we observe for the Tyr24Ala-
Tyr26Ala double mutant are specific to those residues and
not the result of a unfolding of the PFM when these mutations
are performed, we made a direct comparison of molecular
dynamics of wild-type and double mutant lysenin. As shown in
Figure S4, the dynamic fluctuation of the wild-type and double
mutant proteins is the same over a 10 ns period. This shows
that there has been no long range alteration in the lysenin
structure when the mutations are present and that the effects
observed are specific for the absence of the two tyrosines
against which the SM tail aligns.
We also sought to assess the lytic effect of lysenin and its
mutants on Jurkat cells, monitoring pore formation on the
plasma membrane, and subsequent cell death, using the
membrane-impermeable nucleic acid-binding fluorescent dye
SYTOX Green. These experiments were performed by taking07, September 5, 2012 ª2012 Elsevier Ltd All rights reserved 1501
Figure 3. Molecular Details of POCandSMBinding
Sites
(A) Close-up of the POC-binding region within the
C-terminal head domain. Residues directly involved in the
binding are shown as sticks and hydrogen bond and
electrostatic interaction are shown as dash lines.
(B) Electrostatic surface representation of lysenin within an
energy range from 5 to +5 kT, respectively from red to
blue. The dotted line highlights the groove where SM is
bound at the edge of the b sheet.
(C) Close-up of the PFM with SM bound to it. Lysenin is
represented as cartoon and surface. Residues involved
in interaction with SM are represented as sticks. SM is
represented as stick and colored in yellow.
(D) Comparison of SM binding properties of lysenin WT
and its mutants probed by SPR. Overlaid sensograms
previously described lysenin variants show that the
double mutant Y24A-Y26A is unable to interact pro-
ductively with SM. Dot-blot, as inset, confirms that WT
lysenin is able to bind selectively SM but double mutation
Y24AY26A abrogate the binding. *Indicates position of
SM dot.
See also Figure S2 and Movies S1 and S2.
Structure
Structure of Lysenin and Binding to Sphingomyelintime-lapse images over a timeframe of 65 min after addition of
lysenin. The pore-forming effects of the proteins correlate well
with the extent to which lysenin is able to bind SM. In fact,
wild-type (WT) lysenin (Figure 4A and Movie S3) causes the cells
to become SYTOX Green bright within 7 min, whereas the
impaired SM binding variants (Lys21Ala, Gln117Ala, Glu128Ala)
produce a comparable effect between 10 and 13 min (Figures
4B–4D and Movies S4–S6). As expected, the double mutant
Tyr24Ala Tyr26Ala (Figure 4E and Movie S7) has very low pore-
forming activity, with dye permeation completed only in
30 min in a first damaged cell, whereas at the end of the time
lapse period an observable toxic effect could be visualized in
just one-third of the cells. Taken altogether, SPR, dot-blot,
molecular dynamics, and microscopy data confirm that in vivo
SM binding occurs as shown by our SM:lysenin structural model
and that the mutated residues are crucial for engagement of ly-
senin with both the SM headgroup and acyl tail.
Oligomers of Lysenin in the Presence of SM
Lysenin was previously observed to produce a characteristic
oligomeric honeycomb structure in SM-containing membranes
by negative stain electron microscopy (Kwiatkowska et al.,
2007; Yamaji-Hasegawa et al., 2003). However, the lack of struc-
tural data on lysenin oligomers makes it difficult to elucidate the
mechanism of pore formation despite our structural insights1502 Structure 20, 1498–1507, September 5, 2012 ª2012 Elsevier Ltd All rights reservinto the isolated protein. We therefore thought
to image lysenin in a lipid bilayer (Figure S5) by
2D electron crystallography and found that it
generates a putative oligomeric pore placed in
a honeycomb array as previously observed
(Figure 5). This crystal is a trigonal array with
space group p3 (Table 2). We calculated an
electron density map from which we estimated
that the diameter of the trimeric assembly
measures up to 112 A˚, with an inner pore of
57 A˚ (Figure 5). We are not able to model thelysenin oligomeric assembly in more detail because we do not
know the major structural reconfiguration undergone by the
protein upon membrane interaction. However, the overall shape
of the asymmetric unit in the trimeric lattice suggests a side-on
alignment of the protein in the membrane, with pore-forming
regions penetrating the membrane below.
DISCUSSION
In this study, we have described the structure of lysenin, a sphin-
gomyelin-specific pore-forming protein, in its apo form and
bound to POC and SM. By structural analysis we have shown
that lysenin is related to pore-forming proteins from across the
biosphere. It is particularly striking that the homologous N- and
C-terminal domains of fungal LSL (Manchen˜o et al., 2005) and
annelid lysenin are in alternative positions in their respective
sequences. Therefore, during their divergent evolution from
a common ancestral protein, there hasmost likely been a genetic
swap of the two domains with respect to each other. In addition,
the SM-binding region of lysenin is an added edge to the PFM
sheet compared to other pore-forming proteins.
We suggest that lysenin interacts with the membrane initially
by binding of POC in lipids such as SM through its b-trefoil, after
attraction to the membrane surface through charge-charge
affinity; it will then bind the full length of SM. The insight thated
Figure 5. Two-Dimensional ElectronMicroscopy of the Lysenin Pore
(A) Projection map of the crystal in p1 space group.
(B) Projection map of the crystal in p3 space group.
(C) Thresholded projection of the 2D structure at 14 A˚ with the contour map in
p1 space group superimposed.
(D) Thresholded projection of the 2D structure at 14 A˚ with the contour map in
p3 space group superimposed. Symmetry imposition does not introduce any
major changes in the features of the projection map.
See also Figure S5.
Figure 4. Live Cell Imaging of Wild-Type and Mutant Forms of
Lysenin
(A) Confocal laser scanningmicroscopy (CLSM) images of cellswithWT lysenin
at 1 mg/ml and at time zero and 65 s. See Movie S3 for image sequence.
(B) As (A) for the mutant Lys21Ala but see Movie S4.
(C) As (A) for the mutant Glu128Ala but see Movie S5.
(D) As (A) for the mutant Gln117Ala but see Movie S6.
(E) As (A) for the double mutant Tyr24Ala Tyr26Ala but see Movie S7.
See also Figures S3 and S4.
Structure
Structure of Lysenin and Binding to Sphingomyelinlysenin interacts with membranes in a two-stage process is
strengthened by previously published work: removal of the
b-trefoil domain reduces the protein’s affinity 100-fold (Kiyo-
kawa et al., 2005), showing that the C-terminal domain is
needed in membrane binding even though it is the N-terminal
PFM that binds SM specifically. The positively-charged patchStructure 20, 1498–15on the C-terminal domain would make for interactions with
negative charges at the membrane surface, as for example
found at in the case of the sulphates in proteoglycans such as
heparin sulphate and chondroitin sulphate, and may help in at-
tracting or guiding the approach of lysenin to the membrane
surface.
The structure of the SM/lysenin molecular complex repre-
sents, to our knowledge, the first crystal structure showing
a direct and specific SM/protein contact, where not only the
headgroup but also the acyl chain of the lipid is recognized
simultaneously. The interaction with the acyl chains of SM by
lysenin was already shown by differential scanning calorimetry
experiments (Yamaji-Hasegawa et al., 2003). The SM/protein
complex is also in agreement with recently published results
on the molecular recognition of sphingolipids by the protein
transmembrane domain (TMD) of COPI (coat protein) machinery
protein p24 (Contreras et al., 2012) where Fo¨rster resonance
energy transfer (FRET), alanine scanning and molecular dynamic
demonstrated a direct and highly specific interaction of sphin-
gomyelin species with the TMD. Strikingly the interaction
depends on both the head-group and the backbone of the
sphingolipid, as in our structure, and on the presence of a signa-
ture sequence (VXXTLXXIY) within the TMD. The acyl chain of
SM appears to pack in the groove between Val13, Thr16, and
Leu17 of the p24 TMD. One acyl chain of SM also occupies
a groove on the lysenin PFM domain directly interacting with
tyrosines 24 and 26, although it is defined by b strands and not
as in p24 a helices.
To date, interaction with SM has been documented in actino-
porins, which are SM-dependent pore-forming toxins from sea07, September 5, 2012 ª2012 Elsevier Ltd All rights reserved 1503
Table 2. Mean Phase Residuals in Resolution Shells for Merged
2D Crystal Images with p3 Symmetry




Four crystal images corresponding to 5,973 unit cells were merged on
a common p3 phase origin.
Structure
Structure of Lysenin and Binding to Sphingomyelinanemones, only via the SM headgroup and chemical moieties
immediately beneath it (Manchen˜o et al., 2003; Bakrac et al.,
2008). SM occupies a similar position to the lipids found in the
aquaporin-0 2D crystal structure (Hite et al., 2010), and Kir2.2
potassium channel (Hansen et al., 2011). Thus, like the choles-
terol-dependent cytolysins (CDCs), in lysenin specific lipid/
protein interactions lead to membrane disruption as a function
of both the protein inserting into the membrane and the lipid
reorganization induced (Gilbert, 2010). We suggest that binding
of SM in one leaflet of the targeted membrane would result in
its reconfiguration during oligomerization of lysenin, to disrupt
the membrane and form a pore. In this way, by directly binding
to a particular lipid component of the membrane, lysenin can
be specifically targeted and can couple oligomerization to both
its own refolding and the reorganization of the membrane. The
specific binding of SM over its whole length would give oligome-
rizing lysenin sufficient purchase to disrupt the energetically
stable lipid bilayer.
In order to investigate lysenin in its oligomeric state, we
collected electron crystallography images of lysenin in lipo-
somes containing SM. These data allowed us to identify the
trigonal symmetry of the oligomer and estimate its dimensions.
Lysenin pores are known to be small, with an approximate
hydrodynamic diameter of 3 nm (Yamaji-Hasegawa et al.,
2003). The trigonal lattice contains a well-defined trimeric
unit, in which the lysenin monomers appear to lie flat. The
shape of the protomeric unit in this lattice does not look the
same as lysenin in any projection and we cannot say therefore
whether they are monomers or dimers of the protein. The
absence of any extensive hydrophobic regions on lysenin’s
surface, as found in other pore-forming proteins, means that
it is likely similarly to deploy a b-hairpin across the membrane.
A lysenin trimer could only supply three hairpins, or six b strands
that is not enough to form a b-barrel and in itself suggests that
the pore forming state may be a hexamer (a trimer of dimers).
We believe that the structure observed in our 2D crystals is in
fact a pre-pore state. The structures described in this study
suggest that lysenin interacts with POC—not necessarily only
that of SM but also from phosphocholine lipids—via its lectin
domain prior to pre-pore assembly and pore formation. Subse-
quently, it associates with the head group and one full-length
aliphatic tail of the SM molecule, which would serve to deform
the membrane bilayer on the path to pore formation. Overall,
our structures provide a rationale for the further development
of lysenin as a tool for studying the role of SM in membrane
structure, dynamics and function, while explaining the molec-
ular basis of its dependence on SM binding for full activity
(Bruhn et al., 2006).1504 Structure 20, 1498–1507, September 5, 2012 ª2012 Elsevier LtEXPERIMENTAL PROCEDURES
Recombinant Protein Production and Purification
cDNA sequences encoding full-length lysenin were cloned into pTet (Invitro-
gen) in frame with the coding sequence for the thrombin cleavage site and
for six histidine residues at the C terminus of the protein (LVPRGSGHHHHHH).
The lysenin expression plasmid was termed pTetLys1 (Bruhn et al., 2006) and
checked by sequencing for fidelity. Mutations were introduced into the
pTetLys1 by site direct mutagenesis using the XL QuickChange kit (Agilent).
Derivative plasmids were verified by DNA sequencing.
For expression of lysenin, pTetLys1 was transformed into Escherichia coli
strain BL21. The transformed cells were grown in Terrific Broth medium at
22C, with the addition of 100 mg/ml ampicillin in the medium. Identical condi-
tions were adopted to express all lysenin mutated variants. Protein expression
was induced with 0.2 mM anhydro tetracycline when the optical density at
600 nm reached 0.8. After 16 hr, cells were harvested, washed in PBS and
stored at 80C for later use.
For expression of SeMet-labeled protein, B834(DE3) cells were transformed
with pTetLys1 plasmid. Cells were inoculated in Seleno-Met media (Molecular
Dimensions) (Ramakrishnan et al., 1993) supplemented 100 mg/ml ampicillin
and selenomethionine according to recommendations of the supplier. Protein
expression was induced as described above.
Cells were lysed in phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM
KCl, 100 mM Na2HPO4 2 mM KH2PO4, pH 7.4) supplemented with protease
inhibitors (Complete without EDTA, Roche) by a cell disruptor. The clarified
lysate containing the soluble recombinant protein was subjected to immobi-
lized metal affinity chromatography (IMAC) onto an Ni2+-nitrilotriacetic acid-
agarose column (Qiagen), followed by size-exclusion chromatography (SEC)
on a HiLoad Superdex 200 pg 16/60 (GE Healthcare). The protein was eluted
in 20 mM HEPES, 150 mM NaCl, 1 mM b-mercaptoethanol.
The purified native protein was tested for oligomerization in presence of
900 nmol b-octylglucopyranoside and 900 nmol sphingomyelin (brain, porcine;
Avanti Polar Lipids). The rest of the purified protein was used in crystallization
trials.
Crystallization and Data Collection
Native lysenin and selenomethionine-labeled (Se-Met) lysenin were concen-
trated to 10 mg/ml and 200 nl sitting drops were set up using a 1:1 ratio
between protein and precipitant in 96-well Greiner crystallization plates using
a Cartesian dispensing robot (Walter et al., 2005). All crystals were unit soaked
in the mother liquor plus 25% of glycerol as cryosolvent, followed by flash
freezing in liquid nitrogen.
Hexagonal crystals of native lysenin grown in 1.8 M ammonium di-hydrogen
phosphate, 1.0 M sodium acetate pH 4.5 were derivatized by a 45 min soak in
a saturated solution of ethyl mercury phosphate (EMP). A single wavelength
data set (SAD), was collected to 2.54 A˚ resolution at the Hg L-III absorption
edge on beamline BM-14. These crystals belong to space group P6522 with
one molecule in the asymmetric unit.
Hexagonal crystals of Se-Met protein grew in the same crystal form in 1.8 M
ammonium di-hydrogen phosphate, 1.0 M sodium acetate pH 4.5. A three-
wavelength anomalous diffraction (MAD) data set with a resolution limit of
2.8 A˚ was collected at ESRF on beamline BM-14. These crystals before
freezing were soaked in mother liquor and 50 mM phosphocholine (POC).
Triclinic crystals of native lysenin grew at 20C in 1 M MES, 1.6 M magne-
sium sulfate pH 6.5. A 3.3 A˚ native data set was collected at ESRF on beamline
ID14EH3. These crystals belong to space group P1 with four molecules in
the asymmetric unit.
The sphingomyelin:lysenin complex crystals grew from the 1:1 molar mix
(see above) in 0.1 M Bis-Tris pH 5.5, 0.2 M Li2SO4. The sphingomyelin:lysenin
crystal diffracted to 3.1 A˚ at the Diamond Light Source on beamline I04.
These crystals belong to space group C2 with two molecules in the asym-
metric unit.
Structure Determination
The indexing and integration of all data sets was carried out with XDS (Kabsch,
1993), and CCP4 (Collaborative Computational Project, Number 4, 1994)
programs SCALA (Evans, 2006) and TRUNCATE (French and Wilson, 1978)
were used for scaling and merging of diffraction data and calculation ofd All rights reserved
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Cowtan, 2004).
The hexagonal Se-Met and Hg derivative crystals were highly radiation
damage sensitive, and the data processing was performed by selecting the
best frames.
Hg sites were located by SHELXD (Schneider and Sheldrick, 2002) using
the Hg-SAD data collected at the L-III absorption edge from a crystal of the
hexagonal crystal form. The heavy atom substructure was refined and initial
phases were calculated with the program SHARP (de la Fortelle and
Bricogne, 1997). The Se atom positions were located in an anomalous Log-
likelihood gradient map and the Hg and Se substructures were refined and
used for phasing in SHARP, using the native amplitudes in a two-derivative
MIRAS calculation. Density modification in SOLOMON (Abrahams and Leslie,
1996) produced an interpretable electron density map, the C-terminal domain
being especially easily traceable. The preliminary model was built by Bucca-
neer (Cowtan, 2006) and manually completed and corrected in COOT.
This preliminary model was used for molecular replacement with the
program PHASER (McCoy et al., 2007) against the amplitudes of the triclinic
crystal form, locating the first three molecules in the asymmetric unit. The
fourth molecule’s N-terminal domain was then located in a separate search
in Phaser, whereas the C-terminal domain was located in the initial Fo-Fc
type map using the spherically averaged translation function (SAPTF) (Vagin
and Isupov, 2001) as implemented in MOLREP.
The triclinic crystals have well defined density for the N-terminal domain.
The model was therefore completed in the triclinic crystal form. To improve
the electron density of the N-terminal domain in the hexagonal crystal form,
multi-crystal averaging was performed in CCP4-DMMULTI (Cowtan, 1994),
with 5-fold averaging between the native triclinic crystal form (four copies/
asymmetric unit, model phases) and the hexagonal SeMet crystal form
(one copy in the asymmetric unit, MIRAS phases). Separate averaging masks
were used for the N-and C-terminal domains. Despite the high resolution
of the Hg data set the anisotropy of the data was very high and even after
anisotropy correction it was not possible to see clear density for the
N-terminal domain. For this reason no refinement was carried out on this
crystal form.
The Se-Met refined structure was the one used in PHASER to obtain a
molecular replacement solution for the lysenin-sphingomyelin complex. An
omit map was calculated demonstrating presence of the bound lipid using
a combination of CNS 1.3 (Bru¨nger et al., 1998) and auto-BUSTER-TNT
1.11.1 (Blanc et al., 2004).
All structures were refined by auto-BUSTER-TNT 1.11.1 (Blanc et al., 2004).
A TLSMD (Painter and Merritt, 2006) analysis was used to define nine TLS
groups for the Se-Met crystal structure (295 residues), six TLS for each proto-
mer, except the protomer D refined with five TLS, in the native crystal structure
(chain A, 292 residues; chain B, 293 residues; chain C, 289 residues; chain D,
288 residues). Seven TLS were used for protomer A (292 residues) and five for
protomer B (292 residues) in the lysenin sphingomyelin complex. The struc-
tures were validated with MOLPROBITY (Chen et al., 2010). Molecular




positional restraints, after which the restraints weight was increased to 5 Kcal/
mol/A˚2 andproduction simulations run for 10nsoneachsystem,with8 A˚ cutoffs
and PME used for long-range electrostatics (Essmann et al., 1995). Both
the simulations and data analysis were preformed with AMBER11(Case
et al., 2005).
Surface Plasmon Resonance
SPR binding experiments were conducted by using a Biacore X instrument
(GE Healthcare, Biacore) as described elsewhere (Anderluh et al., 2005). The
first flow cell of the L1 sensor chip was covered by 1,200 RU of 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphocholine (POPC) large unilamellar vesicles
(LUV) of 100 nm in diameter and the second flow cell was covered by the
same amount of POPC/sphingomyelin 9/1 (mol/mol) LUV. The concentration
of the proteins was 200 nM in running buffer composed of 10 mM HEPES,
150 mM NaCl, pH 7.4.Structure 20, 1498–15Lipid Dot Blots
The lipid dot blot experiment were performed exactly as described in (Bakrac
et al., 2008) by using 2.5 mg/ml of protein to blot the lipids on SphingoStrips
(Echelon Biosciences).
Electron Microscopy
Images of 2D crystals were assessed and processed with the 2DX software
package (Gipson et al., 2007). Crystal images exhibiting isotropic diffraction
to beyond 20 A˚ were processed by correlation averaging with subsequent
unbending, as implemented in the MRC software suite (Crowther et al.,
1996). The crystal images plane groups of symmetry were assessed by phase
comparison using Allspace (Valpuesta et al., 1994). P3 symmetry and subsets
thereof were indicated. Four images were merged onto a common p3 phase
origin after multiple search and refine iterations in 2DX. The overall phase
residual was calculated in p3 to be 45 at a resolution of 14 A˚. Images were
contoured at 0.23 the SD in the density with solid contours (that represent
protein) for density greater than 20.
Construction of Structural Phylogeny
Superimposition of all PFMs was performed using SHP (Stuart et al., 1979) as
previously reported (Riffel et al., 2002). The phylogenetic tree was calculated
using a pairwise evolutionary distance matrix determined from the superim-
posed domains. The tree representation was generated using the programs
FITCH and DRAWTREE as part of the PHYLIP package (Felsenstein, 1997).
Structural comparisons were displayed using PyMOL.
Live Cell Imaging
Jurkat cells (Schneider et al., 1977) were cultured in 75 ml flasks with RPMI,
10% FCS, 1.5% L-glutamine and 1.5% penicillin and streptomycin. A few
days prior to imaging the cell cultures were passaged by 15% of the primary
cell culture being transferred to new media, so that the cells could be imaged
nearer a log growth phase. Prior to imaging 1 ml of the cell culture was
washed three times in HBS buffer (20 mM HEPES, 150 mM NaCl, pH 7.4),
and spun down between washes at 1,000 rpm (170 3 g) for 3 min. After
removing the supernatant, the cells were placed in 1 ml of HBS and resus-
pended by pipette and 3 s on a vortex shaker. The cell suspension was trans-
ferred to a PAA Labs 3.5 cm confocal Petri dish, with the cell buffer filling the
middle well, immediately above the glass coverslip. Approximately 0.01 ml of
CellMask PM Orange (Invitrogen red fluorescence emission cell membrane
marker) and 0.5 ml of Sytox Green (Invitrogen green fluorescence emission
cell viability marker) were added to the HBS buffered cell culture a few
minutes before imaging.
The PAA Labs Petri dish was immediately transferred to a Zeiss Pecon
XL3 large stage incubator with Pecon Labtek heated insert, attached to an
Axiovert 200M microscope on a Zeiss 510 MetaHead laser scanning
confocal system. The stage incubator temperature was set to 37C. HeNe
laser 453 nm 1.2 mW laser excitation power was set to 5.0% and Argon
laser 488 nm 30 mW laser excitation power set to 0.5%, in order to minimize
light damage to the cells during imaging. After 5 min in the incubator
chamber the Petri dish lid was removed and a time-lapse started, set to
continuous DIC transmission and red/green fluorescence imaging, with
one scan every 13 s, at 1,024 3 1,024 pixels, with 23 averaging applied.
Time-lapse video images were acquired using a Zeiss 633 1.4 NA Plan
Apochromat DIC oil immersion objective set to 13 zoom (i.e., 6303)
magnification.
In order to ensure thorough mixing of lysenin with the cells, it was initially
prediluted in HBS and then 200 ml of that added to 200 ml cells again
in HBS. Lysenin was added at 1 min into the time lapse sequence.
Microscope images were acquired using LMS 510 v4.2 confocal software
and the time-lapse videos were visualized/exported using Zeiss LMS
browser v4.2.
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